RARE vs VANI · rev $350.0M vs $99.2M cap
Ultragenyx (RARE) versus Vivani Medical Inc. (VANI) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Vivani Medical Inc. (VANI) is a biotechnology company listed on NASDAQ.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported VANI revenue for 2025-06-30 was $0. Net income was -$13.4M. VANI currently screens at market cap $99.2M.
RARE currently screens at market cap $2.79B. VANI currently screens at market cap $99.2M.
Not investment advice. Open the RARE and VANI stock pages for the full models.
Not investment advice.